Skip to main content Skip to page footer

Gliomas (grade I-III)

Logo des NCT Heidelberg Logo des NCT Heidelberg
×
 

Gliomas (grade I-III)

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Surgical Study

There are currently no studies available

Radiotherapy Study

Title: Prospective Phase II Trial to Assess Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade Glioma Multicentric, Prospective Interventional, Randomized, Observer Blind Two Arm (Active Control), Parallel Group Investigator-initiated Phase II Trial
Phase: II
Contact: Studienambulanz Strahlentherapie / Kontaktperson
Email-Address: studien.radonk(at)med.uni-heidelberg.de
Clinical Investigator: PD Dr. med. Semi Harrabi
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05964569
EudraCT-Number: Keine Registernummer angegeben.

Metastatic Disease: First-Line-Therapy

Title: ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Phase: III
Contact: Tanja Haut / Kontaktperson
Email-Address: Tanja.Haut(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Antje Wick
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05580562
EudraCT-Number: Siehe EU klinisches Studienregister 2022-502051-56-00

Title: A MultIceNTER Phase I Peptide VaCcine Trial to Exploit NeoePitope-Specific T Cells for the Treatment of H3-Mutated Gliomas - (INTERCEPT-H3)
Phase: I
Contact: Andrea Dormann / Kontaktperson
Email-Address: Andrea.Dormann(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Antje Wick
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04808245
EudraCT-Number: Siehe EU klinisches Studienregister 2018-002874-40

Metastatic Disease: Follow-Up Treatment

There are currently no studies available

Other study

Title: Prekonditionierung motorischer Areale mittels repetitiver navigierter transkranieller Magnetstimulation (rnTMS) zur Verbesserung des neuro-onkologischen und funktionellen Outcomes
Phase: II
Contact: Julia Mattern-Tremper / Kontaktperson
Email-Address: Julia.Mattern(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. Sandro Krieg
Registration: Die Studie ist beim Deutschen Register Klinischer Studien registriert. DRKS00017232
EudraCT-Number: Keine Registernummer angegeben.